Denali Therapeutics Inc.DNLINASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P50
Within normal range
Average
-172.72%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | - |
| 2024 | 0.00% | +100.0% |
| 2023 | -54.45% | +82.1% |
| 2022 | -304.58% | +48.4% |
| 2021 | -590.12% | -2880.1% |
| 2020 | 21.23% | +102.8% |
| 2019 | -769.15% | -2450.1% |
| 2018 | -30.16% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |